Issue Date | Title | Author(s) |
2018-09-01 | Systematic review of the impact of point-of-care testing for influenza on the outcomes of patients with acute respiratory tract infection | Egilmezer, E; Walker, GJ; Bakthavathsalam, P; Peterson, JR; Gooding, JJ; Rawlinson, W; Stelzer-Braid, S |
2013-12-01 | MicroRNA control of interferons and interferon induced anti-viral activity | Sedger, LM |
2019-10-01 | RIPLET, and not TRIM25, is required for endogenous RIG-I-dependent antiviral responses | Hayman, TJ; Hsu, AC; Kolesnik, TB; Dagley, LF; Willemsen, J; Tate, MD; Baker, PJ; Kershaw, NJ; Kedzierski, L; Webb, AI; Wark, PA; Kedzierska, K; Masters, SL; Belz, GT; Binder, M; Hansbro, PM; Nicola, NA; Nicholson, SE |
2018-03-02 | Defining the distinct, intrinsic properties of the novel type i interferon, IFNϵ | Stifter, SA; Matthews, AY; Mangan, NE; Fung, KY; Drew, A; Tate, MD; Soares Da Costa, TP; Hampsey, D; Mayall, J; Hansbro, PM; Minambres, AG; Eid, SG; Mak, J; Scoble, J; Lovrecz, G; DeWeerd, NA; Hertzog, PJ |
2019-07-31 | New therapeutic targets for the prevention of infectious acute exacerbations of COPD: Role of epithelial adhesion molecules and inflammatory pathways | Atto, B; Eapen, MS; Sharma, P; Frey, U; Ammit, AJ; Markos, J; Chia, C; Larby, J; Haug, G; Weber, HC; Mabeza, G; Tristram, S; Myers, S; Geraghty, DP; Flanagan, KL; Hansbro, PM; Sohal, SS |
2021-07 | Viperin interacts with PEX19 to mediate peroxisomal augmentation of the innate antiviral response. | Khantisitthiporn, O; Shue, B; Eyre, NS; Nash, CW; Turnbull, L; Whitchurch, CB; Van der Hoek, KH; Helbig, KJ; Beard, MR |
2022-01 | Clinical features and mechanistic insights into drug repurposing for combating COVID-19. | Asrani, P; Tiwari, K; Eapen, MS; McAlinden, KD; Haug, G; Johansen, MD; Hansbro, PM; Flanagan, KL; Hassan, MI; Sohal, SS |
2016-04 | Targeting the IL-33/IL-13 Axis for Respiratory Viral Infections. | Donovan, C; Bourke, JE; Vlahos, R |
2020-01-14 | Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C. | Tanwar, S; Rhodes, F; Srivastava, A; Trembling, PM; Rosenberg, WM |
2012 | Exploring marine cyanobacteria for lead compounds of pharmaceutical importance. | Uzair, B; Tabassum, S; Rasheed, M; Rehman, SF |